- Capital Rx continues to experience rapid growth on
the back of record demand for JUDI® and its tech-enabled,
full-service pharmacy benefit solutions
NEW
YORK, Aug. 13, 2024 /PRNewswire/ -- Inc.
revealed today that Capital Rx, the full-service pharmacy benefit
manager (PBM) and pharmacy benefit administrator (PBA) advancing
our nation's healthcare infrastructure to improve drug price
visibility and patient outcomes, ranks No. 414 on the 2024 Inc.
5000, its annual list of the fastest-growing private companies in
America. The prestigious ranking provides a data-driven look at the
most successful companies within the economy's most dynamic
segment—its independent, entrepreneurial businesses.
Capital Rx's sustained growth reflects the
market's demand for an independent, modern, and scalable technology
platform.
"Capital Rx's sustained growth is a direct reflection of
the market's demand for an independent, modern technology
platform that easily addresses the needs of today's benefit
plans, but also contemplates the infrastructure required for the
future of healthcare," Co-Founder & CEO AJ Loiacono
said. "JUDI® addresses the growing need for plan sponsors,
both large employers and health plans, to finally be given the
choice to select any pharmacy network, home delivery service,
rebate aggregator, point-solution, and clinical service on a secure
and scalable platform."
The Inc. 5000 class of 2024 represents companies that have
driven rapid revenue growth while navigating inflationary pressure,
the rising costs of capital, and seemingly intractable hiring
challenges. Among this year's top 500 companies, the average median
three-year revenue growth rate is 1,637 percent. In all, this
year's Inc. 5000 companies have added 874,458 jobs to the
economy over the past three years.
"One of the greatest joys of my job is going through the Inc.
5000 list," says Mike Hofman, who
recently joined Inc. as editor-in-chief. "To see all of the
intriguing and surprising ways that companies are transforming
sectors, from health care and AI to apparel and pet food, is
fascinating for me as a journalist and storyteller. Congratulations
to this year's honorees, as well, for growing their businesses fast
despite the economic disruption we all faced over the past three
years, from supply chain woes to inflation to changes in the
workforce."
Capital Rx's JUDI is purpose-built to redefine the level of
operational efficiency required to administrate Medicare, Medicaid,
and commercial plans and prescription claims processing. Currently,
JUDI services millions of lives and is central to Capital Rx's
strategic alliance with Prime Therapeutics, which was announced
earlier this year. Armed with JUDI and absent the inherent
conflicts of interest associated with profiting from dispensing
prescription drugs, Capital Rx is focused on delivering scalable
enterprise software solutions to health plans, health systems, and
other plan sponsors needing open, interoperable solutions.
For complete results of the Inc. 5000, including company
profiles and an interactive database that can be sorted by
industry, location, and other criteria, go to www.inc.com/inc5000.
All 5000 companies are featured on Inc.com starting Tuesday, August 13, and the top 500 appear in the
new issue of Inc. magazine, available on newsstands
beginning Tuesday, August 20.
Methodology
Companies on the 2024 Inc. 5000 are ranked
according to percentage revenue growth from 2020 to 2023. To
qualify, companies must have been founded and generating revenue by
March 31, 2020. They must be
U.S.-based, privately held, for-profit, and independent—not
subsidiaries or divisions of other companies—as of December 31, 2023. (Since then, some on the list
may have gone public or been acquired.) The minimum revenue
required for 2020 is $100,000; the
minimum for 2023 is $2 million. As
always, Inc. reserves the right to decline applicants for
subjective reasons. Growth rates used to determine company rankings
were calculated to four decimal places.
About Inc.
Inc. Business Media is the leading
multimedia brand for entrepreneurs. Through its journalism,
Inc. aims to inform, educate, and elevate the profile of our
community: the risk-takers, the innovators, and the ultra-driven
go-getters who are creating our future. Inc.'s award-winning
work achieves a monthly brand footprint of more than 40 million
across a variety of channels, including events, print, digital,
video, podcasts, newsletters, and social media. Its proprietary
Inc. 5000 list, produced every year since its launch as the Inc.
100 in 1982, analyzes company data to rank the fastest-growing
privately held businesses in the United
States. The recognition that comes with inclusion on this
and other prestigious Inc. lists, such as Female Founders
and Power Partners, gives the founders of top businesses the
opportunity to engage with an exclusive community of their peers,
and credibility that helps them drive sales and recruit talent. For
more information, visit www.inc.com.
For more information on the Inc. 5000 Conference & Gala, to
be held from October 16 to 18 in
Palm Desert, California, please
visit http://conference.inc.com/.
About Capital Rx
Capital Rx is a full-service pharmacy
benefit manager (PBM) and pharmacy benefit administrator (PBA),
advancing our nation's electronic healthcare infrastructure to
improve drug price visibility and patient outcomes. As a Certified
B Corp™, Capital Rx is executing its mission through the deployment
of JUDI®, the company's cloud-native enterprise health platform,
and a Single-Ledger Model™, which increases visibility and reduces
variability in drug prices. JUDI connects every aspect of the
pharmacy ecosystem in one efficient, scalable platform, servicing
millions of members for Medicare, Medicaid, and commercial plans.
Together with its clients, Capital Rx is reimagining the
administration of pharmacy benefits and rebuilding trust in
healthcare. To learn more, visit www.capitalrx.com.
Media Contacts
Michael Passanante, SVP,
Marketing & Communications
Justin Venneri, Director,
Communications
marketing@cap-rx.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/capital-rx-ranks-no-411-on-the-2024-inc-5000-making-the-list-of-americas-fastest-growing-private-companies-for-the-third-year-302220636.html
SOURCE Capital Rx